[ORGANIZATION]
Dr. Celestino Hernández Robau Territorial Oncology-University Hospital
Featured in 1 tracked story · first seen
Situations
Cuba begins clinical trials for cancer drug 2C12
4 clusters · 16 sources · last updated
Latest: Cuba evaluates clinical trial for advanced melanoma treatment
Scientists at Cuba’s Center for Molecular Immunology (CIM) have initiated a phase 1 clinical trial for the monoclonal antibody candidate Anti PDL 2C12. Designed to treat advanced melanoma, the drug functions by stimulati